Kenneth Der

Kenneth Der is an Associate Director of Clinical Pharmacology at Amgen, where they focus on pharmacology modeling and simulation. They have held significant roles in various biopharmaceutical companies, including serving as a Senior Manager of Pharmacometrics at Sangamo Therapeutics and contributing to drug development projects at Horizon Therapeutics. Kenneth has expertise in pharmacokinetics for molecules such as efalizumab and gevokizumab, and has extensive experience in the analysis and presentation of pharmacokinetic studies that support both clinical projects and regulatory submissions. They are currently pursuing a Bachelor’s Degree with a double major in Biochemistry and Biology at the University of California, Riverside.